title: Prevention of infusion reactions to infliximab in paediatric patients with oral acetylsalicylic acid.
authors: Anssi
authors: A
authors: Hämäläinen
authors: Pekka
authors: P
authors: Lahdenne
authors: Anne
authors: A
authors: Wikström
authors: Kristiina
authors: K
authors: Aalto
authors: Kaija-Leena
authors: KL
authors: Kolho
mesh_terms: D000284:Administration, Oral; D000293:Adolescent; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000008:administration & dosage; D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000009:adverse effects*; D001241:Aspirin / Q000008:administration & dosage*; D002648:Child; D064420:Drug-Related Side Effects and Adverse Reactions / Q000139:chemically induced / Q000517:prevention & control*; D005260:Female; D005765:Gastrointestinal Agents / Q000008:administration & dosage / Q000009:adverse effects; D006801:Humans; D015212:Inflammatory Bowel Diseases / Q000188:drug therapy*; D000069285:Infliximab; D007262:Infusions, Intravenous; D008297:Male
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D000911:Antibodies, Monoclonal; D005765:Gastrointestinal Agents; D000069285:Infliximab; D001241:Aspirin